The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19

Isabelle Malhamé; Rohan D'Souza; Matthew P Cheng

doi:10.7326/M20-3106

The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19

Ann Intern Med. 2020 Nov 17;173(10):836-837. doi: 10.7326/M20-3106. Epub 2020 Jun 29.

Authors

Isabelle Malhamé¹, Rohan D'Souza², Matthew P Cheng¹

Affiliations

¹ McGill University, McGill University Health Centre, and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada (I.M., M.P.C.).
² Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada (R.D.).

Abstract

Although the number of clinical trials for patients with COVID-19 is increasing, many exclude pregnant women as participants or do not address pregnancy. This commentary discuss why pregnancy women should be included in clinical trials of interventions for COVID-19.

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Betacoronavirus
COVID-19
Clinical Trials as Topic / ethics*
Coronavirus Infections / drug therapy*
Female
Humans
Pandemics
Pneumonia, Viral / drug therapy*
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Pregnancy Complications, Infectious / virology
Pregnant Women*
Research Subjects*
SARS-CoV-2

Substances

Antiviral Agents